DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Bromocriptine

Bromocriptine

  • Australian Product Information Parlodel® (Bromocriptine Mesilate)

    Australian Product Information Parlodel® (Bromocriptine Mesilate)

  • Schizophrenia Care Guide

    Schizophrenia Care Guide

  • Bromocriptine-A Changing Scene

    Bromocriptine-A Changing Scene

  • Drugs for Parkinson's Disease

    Drugs for Parkinson's Disease

  • Bromocriptine Monograph, Compendium of Pharmaceuticals and Specialties

    Bromocriptine Monograph, Compendium of Pharmaceuticals and Specialties

  • Name of Medicine

    Name of Medicine

  • Package Leaflet: Information for the User Parlodel 2.5 Mg Tablets Bromocriptine Mesilate

    Package Leaflet: Information for the User Parlodel 2.5 Mg Tablets Bromocriptine Mesilate

  • Ergot Alkaloids: a Review on Therapeutic Applications

    Ergot Alkaloids: a Review on Therapeutic Applications

  • Parlodel® Snaptabs® (Bromocriptine Mesylate) Tablets, USP (Bromocriptine Mesylate) Capsules, USP Rx Only Prescribing Information

    Parlodel® Snaptabs® (Bromocriptine Mesylate) Tablets, USP (Bromocriptine Mesylate) Capsules, USP Rx Only Prescribing Information

  • Bromocriptine Patient Handout

    Bromocriptine Patient Handout

  • Bromocriptine Treatment in Parkinson's Disease

    Bromocriptine Treatment in Parkinson's Disease

  • Blockade of Photically Induced Epilepsy by 'Dopamine Agonist' Ergot Alkaloids

    Blockade of Photically Induced Epilepsy by 'Dopamine Agonist' Ergot Alkaloids

  • Blind Trial of Bromocriptine Efficacy in Nonfluent Aphasia After Stroke

    Blind Trial of Bromocriptine Efficacy in Nonfluent Aphasia After Stroke

  • Sexual Side Effects of Psychiatric Medications in Women: a Clinical Review

    Sexual Side Effects of Psychiatric Medications in Women: a Clinical Review

  • Bromocriptine Mesylate Tablets), for Oral Use • Somnolence: May Cause Somnolence

    Bromocriptine Mesylate Tablets), for Oral Use • Somnolence: May Cause Somnolence

  • JRRD Volume 46, Number 6, 2009

    JRRD Volume 46, Number 6, 2009

  • Dopamine Agonists Both Stimulate and Inhibit Prolactin Release In

    Dopamine Agonists Both Stimulate and Inhibit Prolactin Release In

  • Parkinson's Disease: an Open Label Trial of Pergolide in Patients Failing Bromocriptine Therapy

    Parkinson's Disease: an Open Label Trial of Pergolide in Patients Failing Bromocriptine Therapy

Top View
  • Does Methergine Aggravate Chest Symptom And/Or Electrocardiographic Changes During Cesarean Delivery Under Spinal Anesthesia?
  • PERGOLIDE (Veterinary—Systemic)
  • Therapeutic Drug Class
  • Lisuride Reduces Psychomotor Retardation During Withdrawal from Chronic Intravenous Amphetamine Self-Administration in Rats Luigipulvirenti, M.D
  • Impulse Control Disorders in Patients with Hyperpolactinemia Treated With
  • Antipsychoticinduced Hyperprolactinemia
  • Don't Ergo the Ergots (Or Don't Overlook the Benefits of the Rye Fungi) by Robert Mason Phd
  • MR Lee, MR Lee
  • Drug Class Review Selective Serotonin Reuptake Inhibitors
  • Effect of Bromocriptine and Pergolide on Pituitary Tumor Size and Serum Prolactin
  • Bromocriptine in Parkinsonism
  • Glutamate Uptake Into Synaptic Vesicles: Competitive Inhibition by Bromocriptine
  • Neupro, INN-Rotigotine
  • Bromocriptine Mesylate (Cycloset) for Type 2 Diabetes Mellitus CHRISTY M
  • 'Cerebroactive' Drugs Clinical Pharmacology and Therapeutic Role in Cerebrovascular Disorders
  • Psychological Effects of Dopamine Agonist Treatment in Patients With
  • Treatment of Restless Legs Syndrome: an Evidence-Based Review and Implications for Clinical Practice
  • Bromocriptine 2.5Mg Tablets


© 2024 Docslib.org    Feedback